Mast-Cell Stabilizers
Verified · Jul 2026Prototype: cromolyn
Cromolyn — stopping the allergic reaction before it starts by keeping the mast cell’s histamine locked inside.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 Locking the histamine inside the mast cell
The allergic response begins when an allergen cross-links IgE on a mast cell, causing it to degranulate — dumping histamine and other inflammatory mediators that drive bronchoconstriction, mucus, and swelling. Antihistamines block histamine *after* it is released; mast-cell stabilizers act one step earlier — they prevent the mast cell from degranulating in the first place, so the mediators are never released.
This makes them purely preventive. Cromolyn must be taken regularly, before exposure (or before exercise), and it takes days to weeks to reach full effect. The corollary is the single most important teaching point: cromolyn does NOTHING for an acute attack — it cannot reverse bronchospasm that is already happening. A rescue bronchodilator is still required for symptoms.
02 The trade-off: extremely safe, modestly effective
Because cromolyn is barely absorbed systemically and works locally at the mucosa, it is one of the safest respiratory drugs — its main adverse effects are minor local irritation (throat irritation, cough, bad taste, or nasal stinging with the spray). That safety makes it useful in children and pregnancy and for allergic rhinitis (Nasalcrom) and allergic conjunctivitis as well as asthma.
The trade-off is modest potency: it is a second-line controller, generally less effective than inhaled corticosteroids, and its need for frequent, consistent dosing challenges adherence. It fits best as add-on prophylaxis — for example, taken before a known trigger or exercise.
Drug names
Indications
- Prophylaxis (maintenance) of mild persistent asthma — not acute attacks
- Prevention of exercise- or allergen-induced bronchospasm (dose before exposure)
- Allergic rhinitis (nasal) and allergic conjunctivitis (ophthalmic); systemic mastocytosis (oral cromolyn)
Mechanism of action
Stabilize the mast-cell membrane, inhibiting IgE-triggered degranulation and the release of histamine, leukotrienes, and other inflammatory mediators. This prevents (but does not reverse) the early- and late-phase allergic/asthmatic response.
Therapeutic effects — what you'll see working
Success is fewer symptoms and attacks over time with regular use — judged over weeks, not doses. It is prophylaxis; a rescue inhaler is still needed for acute symptoms.
- Fewer asthma/allergy episodes
- Preventing mediator release reduces the frequency and severity of allergic and asthmatic responses with consistent dosing.
- Blunted trigger response
- Dosed before exercise or a known allergen, it blunts the bronchospastic/allergic reaction to that trigger.
Adverse effects
With almost no systemic absorption, the effects are local and minor — the "adverse effect" that matters most is the misconception that it treats acute attacks.
Contraindications
There are few contraindications given the excellent safety profile; the "do not" is really a "do not misuse."
When to hold
Assess before giving — these findings mean hold the dose and act.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Sources
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.